Raymond Dwek

Last updated

    Raymond Allen Dwek CBE FRS FRSC (born 10 November 1941) is a scientist at the University of Oxford and co-founder of the biotechnology company Oxford GlycoSciences Ltd. [1] [2]

    Contents

    Biography

    Dwek was educated at Carmel College, and the University of Manchester, where he studied chemistry (1960–64). He then went to Oxford University and Lincoln College, Oxford, where he completed his DPhil in physical chemistry in 1966. He became Professor of Glycobiology in 1988 in the Department of Biochemistry. He is an emeritus fellow of Exeter College, Oxford [3] and since 2014, emeritus director of the Oxford Glycobiology Institute, [4] which he founded in 1991. From 2000 to 2006, he was also head of the Department of Biochemistry. He was a member of the Board of Scientific Governors at The Scripps Research Institute from 2007 to 2015 and an Institute Professor there in 2008. Dwek was President of the Institute of Biology from 2008 to 2010, overseeing the merger with the UK Science Federation to form the Royal Society of Biology. Dwek was the Kluge Chair of Technology and Society at the Library of Congress in the US in 2007. He was scientific advisor to the presidents of Ben-Gurion University of the Negev in Israel from 1997 to 2019, where he helped to build the National Institute of Biotechnology in the Negev. He was also scientific advisor to the Institute of Biochemistry in Bucharest. Dwek was co-chair of the UK/Israel Science Council from 2012 to 2017. Since 2013, Dwek has been a member of the scientific governing board of the newly established ShanghaiTech University.

    Academic and scientific career

    Dwek read chemistry (1960–64) at the University of Manchester. He completed his DPhil in physical chemistry at Oxford in 1966. Following this, he became a research lecturer at Christ Church, Oxford, where he taught physical and inorganic chemistry. In 1969, he was invited to join the Biochemistry Department, working with other members of the Oxford Enzyme Group. In 1974, he was elected Royal Society Locke Research fellow, working on antibodies. This led to his appointment as university lecturer in biochemistry with a fellowship, by special election, at Exeter College in 1976. At the same time, he was also appointed a lecturer in biochemistry at Trinity College to help build up the subject there.

    Dwek's research on antibodies led directly to defining the function of the attached oligosaccharides and from which the field of glycobiology emerged – a word coined by Dwek which entered the Oxford English Dictionary in 1992. [5] In 1988, Dwek was made Professor of Glycobiology. In 1985, Dwek secured the first industrial grant to Oxford University in its 950-year history, from Monsanto Company USA, which was developing a pharmaceutical arm. The grant was to develop the technology for sequencing oligosaccharides. Over 13 years the value of the grant was almost $100M. In 1991, Dwek became Director of the Glycobiology Institute which he founded and which was built with funds from Monsanto/Searle.

    Also in 1988, Dwek was the founding scientist and non-executive director of Oxford GlycoSciences Plc (formerly Oxford GlycoSystems), which was established to commercialise technologies arising from his research at the Glycobiology Institute. In 1995, the company was mentioned as part of the Queen's Anniversary Prize to the University of Oxford. In 1998, it was publicly quoted on the London Stock Exchange.

    In 2002 in collaboration with Glycobiology Institute, Oxford GlycoSciences had a drug [6] for Gaucher disease approved worldwide.

    In 1998, Dwek was also the founding scientist and chairman of the Scientific Board and Director of Synergy, which was established in the United States to develop antiviral agents for the treatment of chronic Hepatitis B and C infections. This work was taken over by United Therapeutics, USA, and Dwek became a director [7] of this company in 2002 and continues this appointment. The company sponsored the antiviral laboratory at the Glycobiology Institute from 2002 to 2017 and continues its sponsorship of the Annual Unither Barry Blumberg Virology Lecture [8] at Oxford University (2004-2027).

    Dwek is the author of Nuclear Magnetic Resonance (NMR) in biochemistry – application to enzyme systems (OUP, 1973), Principles and Problems in Physical Chemistry for Biochemists, with N C Price (OUP, 1974) and Biology Spectroscopy with I D Campbell (Benjamin Cummings, 1984). He has published over 600 peer reviewed articles and about 100 patents.

    Awards and recognition

    Dwek has received honorary doctorates from the Katholieke Universiteit Leuven, Belgium (1996), Ben-Gurion University of the Negev, Israel (2001), the Scripps Research Institute, USA (2004), Cluj University, Romania (2006) and University College Dublin, Ireland (2010).

    Other honours include the 7th Wellcome Trust Award for Research in Biochemistry Related to Medicine (1994), the First Scientific Leadership Award of the Hepatitis B Foundation (1997), The Romanian Order of Merit (2000), the Huxley Medal of the Institute of Biology (2007) and the K.T. Wang Bioorganic Chemistry Prize and Lecture, Taiwan. He held the Kluge Chair in Technology and Society at the Library of Congress, USA in 2007. He is an Honorary Fellow of Lincoln College, Oxford (2004). He was a director of ISIS Innovation (now called Oxford University Innovation, OUI) – the University's Intellectual Property Company (2003–8). He was the founding Chairman of Oxford University Consulting, now part of OUI.

    Dwek was elected a member of the European Molecular Biology Organization in 1988, a Fellow of the Royal Society of Chemistry in 1993, a Fellow of the Royal Society in 1998, a foreign member of the American Philosophical Society in 2006, and Hon Fellow of the Royal College of Physicians in 2007. He was the head of the Biochemistry Department from 2000 to 2007 and President of the Institute of Biology from 2008 to 2010. He is a founding member of the UK-Israel Science Council and served as its co-chair alongside Professor Rivka Carmi in the years 2010–2017. [9]

    Dwek was appointed Commander of the Order of the British Empire (CBE) in the 2013 New Year Honours for services to UK/Israel scientific collaboration [10] and in 2018 received a Lifetime Achievement Award from Ben-Gurion University.

    Published works

    Related Research Articles

    <span class="mw-page-title-main">Aaron Klug</span> British biophysicist and chemist (1926–2018)

    Sir Aaron Klug was a British biophysicist and chemist. He was a winner of the 1982 Nobel Prize in Chemistry for his development of crystallographic electron microscopy and his structural elucidation of biologically important nucleic acid-protein complexes.

    <span class="mw-page-title-main">Raymond Lemieux</span> Canadian organic chemist (1920–2000)

    Raymond Urgel Lemieux, CC, AOE, FRS was a Canadian organic chemist, who pioneered many discoveries in the field of chemistry, his first and most famous being the synthesis of sucrose. His contributions include the discovery of the anomeric effect and the development of general methodologies for the synthesis of saccharides still employed in the area of carbohydrate chemistry. He was a fellow of the Royal Society of Canada and the Royal Society (England), and a recipient of the prestigious Albert Einstein World Award of Science and Wolf Prize in Chemistry.

    Jacob Klein, is the Herman Mark Professor of Soft Matter Physics at the Weizmann Institute in Rehovot, Israel. He is well known for his work in soft condensed matter, polymer science and surface science.

    <span class="mw-page-title-main">Department of Biochemistry, University of Oxford</span>

    The Department of Biochemistry of Oxford University is located in the Science Area in Oxford, England. It is one of the largest biochemistry departments in Europe. The Biochemistry Department is part of the University of Oxford's Medical Sciences Division, the largest of the university's four academic divisions, which has been ranked first in the world for biomedicine.

    Richard D. Cummings is an American biochemist who is the S. Daniel Abraham Professor of Surgery at Beth Israel Deaconess Medical Center and Harvard Medical School in Boston, Massachusetts. He also the chief of the division of surgical sciences within the department of surgery. He is the director of the Harvard Medical School Center for Glycoscience, director of the National Center for Functional Glycomics, and also founder of the Glycomics Core at BIDMC. As of 2018 Cummings is also the scientific director of the Feihi Nutrition Laboratory at BIDMC. Before moving to BIDMC/HMS, Cummings was the William Patterson Timmie Professor and chair of the department of biochemistry at Emory University School of Medicine in Atlanta, Georgia from 2006 to 2015. At Emory, Cummings was a founder in 2007 of the Emory Glycomics Center.

    Thomas Dean Pollard is a prominent educator, cell biologist and biophysicist whose research focuses on understanding cell motility through the study of actin filaments and myosin motors. He is Sterling Professor Emeritus of Molecular, Cellular & Developmental Biology and a professor emeritus of cell biology and molecular biophysics & biochemistry at Yale University. He was dean of Yale's Graduate School of Arts and Sciences from 2010 to 2014, and president of the Salk Institute for Biological Studies from 1996 to 2001.

    <span class="mw-page-title-main">David E. Cane</span> American biochemist

    David E. Cane is an American biological chemist. He is Vernon K. Krieble Professor of Chemistry Emeritus and professor of molecular biology, cell biology, and biochemistry emeritus at Brown University in Providence, Rhode Island. He is recognized for his work on the biosynthesis of natural products, particularly terpenoids and polyketides. He was elected as a Fellow of the American Association for the Advancement of Science in 2003 and as a Fellow of the American Academy of Arts and Sciences in 2013.

    <span class="mw-page-title-main">Anne Glover (biologist)</span> Scottish biologist (born 1956)

    Dame Lesley Anne Glover is a Scottish biologist and academic. She was Professor of molecular biology and cell biology at the University of Aberdeen before being named Vice Principal for External Affairs and Dean for Europe. She served as Chief Scientific Adviser to the President of the European Commission from 2012 to 2014. In 2018 she joined the Principal's senior advisory team at the University of Strathclyde.

    <span class="mw-page-title-main">James Naismith (chemist)</span> British structural biologist

    James Henderson Naismith is Professor of Structural Biology at the University of Oxford, former Director of the Research Complex at Harwell and Director of the Rosalind Franklin Institute. He previously served as Bishop Wardlaw Professor of Chemical Biology at the University of St Andrews. He was a member of Council of the Royal Society (2021-2022). He is currently the Vice-Chair of Council of the European X-ray Free Electron Laser and Vice-President (non-clinical) of The Academy of Medical Sciences. It has been announced that he will be the Head of the MPLS division at Oxford in the autumn of 2023.

    <span class="mw-page-title-main">Ben G. Davis</span> Professor of Chemistry, in the Department of Chemistry at the University of Oxford

    Benjamin Guy Davis is Professor of Chemical biology in the Department of Pharmacology and a member of the Faculty in the Department of Chemistry at the University of Oxford and a Fellow of Pembroke College, Oxford. He holds the role of Science Director for Next Generation Chemistry (2019-2024) and Deputy (2020-) and Interim Director at the Rosalind Franklin Institute.

    James C. Paulson is an American biochemist and biologist known for his work in glycobiology.

    <span class="mw-page-title-main">Nigel Scrutton</span> British biochemist (born 1964)

    Nigel Shaun Scrutton is a British biochemist and biotechnology innovator known for his work on enzyme catalysis, biophysics and synthetic biology. He is Director of the UK Future Biomanufacturing Research Hub, Director of the Fine and Speciality Chemicals Synthetic Biology Research Centre (SYNBIOCHEM), and Co-founder, Director and Chief Scientific Officer of the 'fuels-from-biology' company C3 Biotechnologies Ltd. He is Professor of Enzymology and Biophysical Chemistry in the Department of Chemistry at the University of Manchester. He is former Director of the Manchester Institute of Biotechnology (MIB).

    Robert L. Hill (1928-2012) was a biochemist who spent most of his career on the faculty at Duke University School of Medicine, from which he retired as the James B. Duke Professor Emeritus. Hill's research focused on the chemistry of enzymes, with particular specialization in glycosyltransferases and glycobiology.

    <span class="mw-page-title-main">Zvi HaCohen</span> Israeli scientist and university official

    Prof. Zvi HaCohen is an Israeli scientist who, since August 2010, has served as Rector of Ben-Gurion University of the Negev (BGU).

    Stuart Arthur Kornfeld is a professor of medicine at Washington University in St. Louis and researcher in glycobiology.

    Ute Deichmann is an historian of modern life sciences. She is adjunct full professor at Ben-Gurion University of the Negev in Israel, where she was the founding director of the Jacques Loeb Centre for the History and Philosophy of the Life Sciences in 2007 and continues to be the director. She has also been an associate professor at the University of Cologne, Germany since 2011.

    <span class="mw-page-title-main">Charles E. Warren</span> American glycobiologist (1962–2005)

    Charles E. Warren was an assistant professor of biochemistry and molecular biology at the University of New Hampshire.

    <span class="mw-page-title-main">Ashraf Brik</span> Israeli researcher

    Ashraf Brik is a full professor at the Schulich Faculty of Chemistry at the Technion Institute of Technology, Israel. His laboratory specializes in developing synthetic methods for chemical synthesis of proteins with post-translational modifications (PTMs) in quantities that allow for them to be studied thoroughly. Brik's group is developing novel modulators based on small molecules, peptides and peptidomimetics, to influence enzymes and proteins involved in various diseases. With the help of these tools, it is possible to understand how molecules and biological systems affect health.

    Nicki Packer FRSC is an Australian college professor and researcher. She currently serves as a distinguished professor of glycoproteomics in the School of Natural Sciences at Macquarie University and principal research leader at Griffith University's Institute for Glycomics. Packer is a Fellow of the Royal Society of Chemistry and in 2021 received the Distinguished Achievement in Proteomic Sciences Award from the Human Proteome Organization. Her research focuses on biological functional of glycoconjugates by linking glycomics with proteomics and bioinformatics.

    Pauline Rudd is a British biochemist and Professor at the Microbiome Institute, University College Cork. She is a founder of Wessex Biochemicals, a Fellow of the Royal Society of Medicine and was awarded the James Gregory Medal in 2010.

    References

    1. Siegel-Itzkovich, Judy (13 February 2011). "Enemy of disease, friend of Israel". Jerusalem Post. Retrieved 27 March 2023.
    2. Dwek, Raymond A. (2014). "Journeys in Science: Glycobiology and Other Paths". Annual Review of Biochemistry. 83: 1–44. doi: 10.1146/annurev-biochem-041612-095236 . PMID   24437663.
    3. "Professor Raymond Dwek". Exeter College}. Retrieved 4 January 2024.
    4. "OGI" . Retrieved 4 January 2024.
    5. glycobiology, n, OED
    6. "Zavesca EPAR". European Medicines Agency (EMA). 17 September 2018. Archived from the original on 5 August 2020. Retrieved 7 August 2020.
    7. "UTH" . Retrieved 4 January 2024.}
    8. "Annual Baruch Blumberg lecture" . Retrieved 4 January 2024.
    9. "UK-Israel Science Council". British Council . Retrieved 24 July 2017.
    10. "No. 60367". The London Gazette (Supplement). 29 December 2012. p. 25.